← back to search

Zhongxu Sun

Nanjing University of Chinese Medicine · CN
Area of research
Endocrinology, Diabetes and Metabolism · Pulmonary and Respiratory Medicine
Research interest
Research interests include Abdominal aortic aneurysm, Vascular smooth muscle, Phenotypic switching, Aneurysm, Biology, and Transcription factor.
h-index
citations
40
works
2
NIH funding
primary concept
email

Recent publications

Ras-related protein 2 limits vascular smooth muscle cell phenotypic switching and abdominal aortic aneurysm development
Nature Communications 2025cited by 1position: middledoi
SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm
Journal of Clinical Investigation 2024cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoqi Wu · Nanjing University of Chinese Medicine2 papers (2024–2025)Tianyu Song · Dalian University of Technology2 papers (2024–2025)Liping Xie · Nanjing University of Chinese Medicine2 papers (2024–2025)Shanshan Luo · Technical University of Munich2 papers (2024–2025)Zhi‐Ren Zhang · Harbin Medical University2 papers (2024–2025)Shan-zhen Sun · Harbin Medical University1 papers (2025–2025)Dongjin Wang · Nanjing Medical University1 papers (2025–2025)Shuang Zhao · Nanjing University of Chinese Medicine1 papers (2024–2024)Yi Han · Zhejiang Chinese Medical University1 papers (2025–2025)Aihua Gu · Nanjing Medical University1 papers (2025–2025)Yong Ji · Shaoxing City Women and Children Hospital1 papers (2025–2025)Zhi‐Jian Han · Nanjing Medical University1 papers (2024–2024)Ke Zhong · Nanjing Medical University1 papers (2025–2025)Yong Ji · Nanjing University of Chinese Medicine1 papers (2024–2024)Yineng Wang · Nanjing University of Chinese Medicine1 papers (2024–2024)Kangyun Sun · Nanjing Medical University1 papers (2024–2024)Hongshan Chen · Nanjing University of Chinese Medicine1 papers (2024–2024)Feng Chen · Nanchang University1 papers (2024–2024)Xiaoqiang Li · Air Force Engineering University1 papers (2024–2024)Feng Chen · China National Petroleum Corporation (China)1 papers (2025–2025)